Laurus Labs Limited
Indian Pharmaceutical Exporter ยท Antiviral & HIV Medications Specialist ยท $3.2M Total Trade ยท DGFT Verified
Laurus Labs Limited is an Indian pharmaceutical exporter with a total trade value of $3.2M across 4 products in 2 therapeutic categories. Based on 64 verified export shipments from Indian Customs (DGFT) records, the company actively competes across multiple product segments. Top exports include Dolutegravir ($1.9M), Sitagliptin ($500.0K), Emtricitabine ($400.0K).
Laurus Labs Limited โ Export Portfolio & Destination Treemap

Who is Laurus Labs Limited? โ Company Overview & Market Position
Laurus Labs Limited, established in 2005 by Dr. Satyanarayana Chava, is a Hyderabad-based Indian multinational pharmaceutical and biotechnology company. The company specializes in the development, manufacture, and sale of active pharmaceutical ingredients (APIs), generic formulations, and contract development and manufacturing services (CDMO). Its product portfolio spans therapeutic areas such as antiretrovirals, oncology, and cardiovascular diseases. As of 2022, Laurus Labs employs approximately 5,700 individuals. The company's website is www.lauruslabs.com.